Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
David B Price, William Henley, José Eduardo Delfini Cançado, Leonardo M Fabbri, Huib A M Kerstjens, Alberto Papi, Nicolas Roche, Elif Şen, Dave Singh, Claus F Vogelmeier, Sara Barille, Elena Nudo, Victoria Carter, Derek Skinner, Rebecca Vella & George Georges. (2022) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 355-370.
Read now
Read now
Alessia Romagnoli, Fiorenzo Santoleri & Alberto Costantini. (2020) Adherence and persistence analysis after three years in real-life of inhalation therapies used in the treatment of COPD. Current Medical Research and Opinion 36:12, pages 2055-2061.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Read now
Brian W. Carlin, Sandra K. Schuldheisz, Imre Noth & Gerard J. Criner. (2017) Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. Postgraduate Medicine 129:7, pages 725-733.
Read now
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Darcy D. Marciniuk, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D'Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Denis E. O'Donnell & Don D. Sin. (2017) CTS position statement: Pharmacotherapy in patients with COPD—An update. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 1:4, pages 222-241.
Read now
Read now
Andrea Rossi, Erika Zanardi, Venerino Poletti & Mario Cazzola. (2015) Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1383-1392.
Read now
Read now
Articles from other publishers (15)
Hilla Mills, Ronald Acquah, Nova Tang, Luke Cheung, Susanne Klenk, Ronald Glassen, Magali Pirson, Alain Albert, Duong Trinh Hoang & Thang Nguyen Van. (2022) Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD). Emergency Medicine International 2022, pages 1-5.
Crossref
Crossref
J.M. Figueira Gonçalves, R. Golpe, C. Esteban, M. Acosta-Sorensen, I. Veiga & I. Guzmán-Peralta. (2021) Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC guideline vs. GOLD. Revista Clínica Española (English Edition) 221:9, pages 536-539.
Crossref
Crossref
J.M. Figueira Gonçalves, R. Golpe, C. Esteban, M. Acosta-Sorensen, I. Veiga & I. Guzmán-Peralta. (2021) Discordancia del tratamiento de la enfermedad pulmonar obstructiva crónica según la guía GesEPOC vs. GOLD. Revista Clínica Española 221:9, pages 536-539.
Crossref
Crossref
Muhammad Salman Sajid, Shafaq Saleem, Fahmida Jabeen, Batool Fatima, Adeela Saeed, Dilshad Hussain, Saadat Majeed, Muhammad Naeem Ashiq & Muhammad Najam-ul-Haq. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance
235
254
.
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, A. V. Emel'yanov, I. V. Demko, G. L. Ignatova, I. N. Trofimenko & E. I. Shmelev. (2020) Inhalation glucocorticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 30:3, pages 330-343.
Crossref
Crossref
Donald P. Tashkin. (2020) Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD. Chest 157:5, pages 1067-1069.
Crossref
Crossref
Maurice Driessen, Dhvani Shah, Nancy Risebrough, Timothy Baker, Ian Naya, Andrew Briggs & Afisi S. Ismaila. (2018) Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective. Respiratory Medicine 145, pages 130-137.
Crossref
Crossref
Donald P. Tashkin. (2018) To Withdraw or Not to Withdraw Inhaled Corticosteroids from Triple Therapy in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 198:3, pages 292-294.
Crossref
Crossref
Štefan Laššán, Marta Hájková & Monika Laššánová. (2017) Anti-inflammatory treatment of stable COPD - current trends and recommendations for clinical practiceExperts statement. Klinická farmakologie a farmacie 31:1, pages 22-30.
Crossref
Crossref
Marc Miravitlles, Anthony D’Urzo, Dave Singh & Vladimir Koblizek. (2016) Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review. Respiratory Research 17:1.
Crossref
Crossref
Valeria Belleudi, Mirko Di Martino, Silvia Cascini, Ursula Kirchmayer, Riccardo Pistelli, Giulio Formoso, Danilo Fusco, Marina Davoli & Nera Agabiti. (2016) The impact of adherence to inhaled drugs on 5‐year survival in COPD patients: a time dependent approach. Pharmacoepidemiology and Drug Safety 25:11, pages 1295-1304.
Crossref
Crossref
Kai M. Beeh. (2016) The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease. Tuberculosis and Respiratory Diseases 79:4, pages 241.
Crossref
Crossref
Almotasembellah Aljaafareh, Jose Ruben Valle, Yu-Li Lin, Yong-Fang Kuo & Gulshan Sharma. (2016) Risk of cardiovascular events after initiation of long-acting bronchodilators in patients with chronic obstructive lung disease: A population-based study. SAGE Open Medicine 4, pages 205031211667133.
Crossref
Crossref
Deborah Weatherspoon, Christopher A. Weatherspoon & Brianna Abbott. (2015) Pharmacology Update on Chronic Obstructive Pulmonary Disease, Rheumatoid Arthritis, and Major Depression. Nursing Clinics of North America 50:4, pages 761-770.
Crossref
Crossref
James F. Donohue, Sally Worsley, Chang-Qing Zhu, Liz Hardaker & Alison Church. (2015) Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations. Respiratory Medicine 109:7, pages 870-881.
Crossref
Crossref